Literature DB >> 24144905

Integrated platform for functional monitoring of biomimetic heart sheets derived from human pluripotent stem cells.

Aaron Chen1, Eugene Lee, Roger Tu, Kevin Santiago, Anna Grosberg, Charless Fowlkes, Michelle Khine.   

Abstract

We present an integrated platform comprised of a biomimetic substrate and physiologically aligned human pluripotent stem cell-derived cardiomyocytes (CMs) with optical detection and algorithms to monitor subtle changes in cardiac properties under various conditions. In the native heart, anisotropic tissue structures facilitate important concerted mechanical contraction and electrical propagation. To recapitulate the architecture necessary for a physiologically accurate heart response, we have developed a simple way to create large areas of aligned CMs with improved functional properties using shrink-wrap film. Combined with simple bright field imaging, obviating the need for fluorescent labels or beads, we quantify and analyze key cardiac contractile parameters. To evaluate the performance capabilities of this platform, the effects of two drugs, E-4031 and isoprenaline, were examined. Cardiac cells supplemented with E-4031 exhibited an increase in contractile duration exclusively due to prolonged relaxation peak. Notably, cells aligned on the biomimetic platform responded detectably down to a dosage of 3 nM E-4031, which is lower than the IC50 in the hERG channel assay. Cells supplemented with isoprenaline exhibited increased contractile frequency and acceleration. Interestingly, cells grown on the biomimetic substrate were more responsive to isoprenaline than those grown on the two control surfaces, suggesting topography may help induce more mature ion channel development. This simple and low-cost platform could thus be a powerful tool for longitudinal assays as well as an effective tool for drug screening and basic cardiac research.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiomyocytes; Contractile properties; Drug screening; Human pluripotent stem cells

Mesh:

Substances:

Year:  2013        PMID: 24144905      PMCID: PMC9300448          DOI: 10.1016/j.biomaterials.2013.10.007

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   15.304


  34 in total

Review 1.  Can the pharmaceutical industry reduce attrition rates?

Authors:  Ismail Kola; John Landis
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

2.  Shrink-film configurable multiscale wrinkles for functional alignment of human embryonic stem cells and their cardiac derivatives.

Authors:  Aaron Chen; Deborah K Lieu; Lauren Freschauf; Valerie Lew; Himanshu Sharma; Jiaxian Wang; Diep Nguyen; Ioannis Karakikes; Roger J Hajjar; Ajay Gopinathan; Elliot Botvinick; Charless C Fowlkes; Ronald A Li; Michelle Khine
Journal:  Adv Mater       Date:  2011-11-08       Impact factor: 30.849

3.  Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes.

Authors:  Hoi Ting Heidi Au; Bo Cui; Zane E Chu; Teodor Veres; Milica Radisic
Journal:  Lab Chip       Date:  2008-11-19       Impact factor: 6.799

4.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.

Authors:  M C Sanguinetti; N K Jurkiewicz
Journal:  J Gen Physiol       Date:  1990-07       Impact factor: 4.086

5.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.

Authors:  Z Zhou; Q Gong; B Ye; Z Fan; J C Makielski; G A Robertson; C T January
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

6.  Noninvasive evaluation of contractile behavior of cardiomyocyte monolayers based on motion vector analysis.

Authors:  Tomohiro Hayakawa; Takeshi Kunihiro; Suguru Dowaki; Hatsume Uno; Eriko Matsui; Masashi Uchida; Seiji Kobayashi; Akio Yasuda; Tatsuya Shimizu; Teruo Okano
Journal:  Tissue Eng Part C Methods       Date:  2011-10-11       Impact factor: 3.056

7.  The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes.

Authors:  Shengde Peng; Antonio E Lacerda; Glenn E Kirsch; Arthur M Brown; Andrew Bruening-Wright
Journal:  J Pharmacol Toxicol Methods       Date:  2010-02-11       Impact factor: 1.950

Review 8.  Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.

Authors:  Carl-Fredrik Mandenius; Daniella Steel; Fozia Noor; Thomas Meyer; Elmar Heinzle; Julia Asp; Sarina Arain; Udo Kraushaar; Susanne Bremer; Reiner Class; Peter Sartipy
Journal:  J Appl Toxicol       Date:  2011-02-16       Impact factor: 3.446

9.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

Review 10.  Basic mechanisms of cardiac impulse propagation and associated arrhythmias.

Authors:  André G Kléber; Yoram Rudy
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

View more
  16 in total

1.  Micro- and nano-patterned elastin-like polypeptide hydrogels for stem cell culture.

Authors:  A Paul; M Stührenberg; S Chen; D Rhee; W-K Lee; T W Odom; S C Heilshorn; A Enejder
Journal:  Soft Matter       Date:  2017-08-30       Impact factor: 3.679

2.  Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales.

Authors:  Nathaniel Huebsch; Peter Loskill; Mohammad A Mandegar; Natalie C Marks; Alice S Sheehan; Zhen Ma; Anurag Mathur; Trieu N Nguyen; Jennie C Yoo; Luke M Judge; C Ian Spencer; Anand C Chukka; Caitlin R Russell; Po-Lin So; Bruce R Conklin; Kevin E Healy
Journal:  Tissue Eng Part C Methods       Date:  2015-01-14       Impact factor: 3.056

3.  Enhanced emission of fluorophores on shrink-induced wrinkled composite structures.

Authors:  Himanshu Sharma; Michelle A Digman; Natasha Felsinger; Enrico Gratton; Michelle Khine
Journal:  Opt Mater Express       Date:  2014       Impact factor: 3.442

Review 4.  Biomaterial based cardiac tissue engineering and its applications.

Authors:  Locke Davenport Huyer; Miles Montgomery; Yimu Zhao; Yun Xiao; Genevieve Conant; Anastasia Korolj; Milica Radisic
Journal:  Biomed Mater       Date:  2015-05-20       Impact factor: 3.715

Review 5.  Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Authors:  Yosuke K Kurokawa; Steven C George
Journal:  Adv Drug Deliv Rev       Date:  2015-07-23       Impact factor: 15.470

Review 6.  Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.

Authors:  Alec S T Smith; Jesse Macadangdang; Winnie Leung; Michael A Laflamme; Deok-Ho Kim
Journal:  Biotechnol Adv       Date:  2016-12-20       Impact factor: 14.227

7.  All-Polymer Printed Low-Cost Regenerative Nerve Cuff Electrodes.

Authors:  Laura M Ferrari; Bruno Rodríguez-Meana; Alberto Bonisoli; Annarita Cutrone; Silvestro Micera; Xavier Navarro; Francesco Greco; Jaume Del Valle
Journal:  Front Bioeng Biotechnol       Date:  2021-02-10

Review 8.  Thermally-induced miniaturization for micro- and nanofabrication: progress and updates.

Authors:  Sophia Lin; Eugene K Lee; Nancy Nguyen; Michelle Khine
Journal:  Lab Chip       Date:  2014-07-30       Impact factor: 7.517

Review 9.  Mechanochemical engineering of 2D materials for multiscale biointerfaces.

Authors:  Catherine E Machnicki; Fanfan Fu; Lin Jing; Po-Yen Chen; Ian Y Wong
Journal:  J Mater Chem B       Date:  2019-07-10       Impact factor: 7.571

Review 10.  Micro- and nanoscale biophysical cues for cardiovascular disease therapy.

Authors:  Priya Mohindra; Tejal A Desai
Journal:  Nanomedicine       Date:  2021-02-09       Impact factor: 6.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.